| Similar Articles |
|---|
 |
The Motley Fool
May 2, 2006
Stephen D. Simpson |
Still Fishing for Value at Fisher At the right price, this would be an interesting play on health care and biomedical research. Investors, take note.   |
The Motley Fool
May 8, 2006
Stephen D. Simpson |
Fisher Scientific Reels In a Deal A fair price and impressive market leverage give this merger between Fisher Scientific and Thermo Electron a better-than-average chance. Shareholders, take note. |
The Motley Fool
October 26, 2007
Brian Orelli |
This Just In: Mergers Do Indeed Lower Costs As the anniversary integration between Thermo Electron and Fisher Scientific approaches next week, Thermo Fisher Scientific announced third-quarter results that demonstrated how the integration is having a nice effect on the bottom line. |
The Motley Fool
November 3, 2011
Keki Fatakia |
Should You Be Worried About Danaher? Danaher reports 46% higher revenues, but why are profits down? |
The Motley Fool
August 16, 2007
Brian Orelli |
More Drugmaker Growth Without the FDA All that high-tech lab equipment has to come from somewhere. Here's how investors can benefit from it, too. |
The Motley Fool
August 7, 2006
Stephen D. Simpson |
Affymetrix: Price Always Matters Affymetrix has legit technology, but that doesn't mean it has infinite value for investors. |
Bio-IT World
March 2006
Robert M. Frederickson |
Integration, Robotics, and Automation The integration of instruments and technology is a key concept driving the development of advanced life-sciences laboratory automation. More sophisticated robotics are also increasingly being integrated into automated systems. |
The Motley Fool
April 5, 2007
Billy Fisher |
Another Boost for Immucor Since trading for pennies a share in 2001, shares of Immucor have been on a blistering pace. After the release of the company's third-quarter earnings recently, there's no apparent letup in sight, either. |
The Motley Fool
August 26, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Deutsche Securities took the bull side of Wall Street's bearish, anti-medical devices trade, initiating coverage of diagnostic equipment maker China Medical Technologies and reinitiating coverage of Mindray Medical, both with buys. |
The Motley Fool
February 7, 2008
Brian Orelli |
A Lab Match Made in Heaven The case of Thermo Electron and Fisher Scientific shows why mergers work. |
The Motley Fool
October 4, 2007
Billy Fisher |
Immucor Draws First Blood The blood-testing equipment maker sees double-digit growth in both sales and earnings in Q1. |
